The robust 2026 IPO window, with 109 deals raising $146.5 billion through mid-September and pacing toward the strongest U.S. year since 2021, underpins elevated trader-implied odds for several high-profile listings before year-end. Record proceeds reflect strong equity market risk appetite, AI-driven demand, and supportive valuations, as seen in SpaceX’s June debut and recent pricings such as ADARx Pharmaceuticals. However, Q3 activity moderated amid AI spending concerns, 19-year highs in Treasury yields, and selective investor response to growth stories beyond mega-cap tech. Key near-term catalysts include Oura’s expected late-September Nasdaq debut, Anthropic’s potential Q4 filing, and pipeline names like Discord and Cerebras, where market-implied probabilities range from roughly 35% to over 80% depending on the issuer. Broader resolution hinges on sustained earnings momentum and stable monetary policy into December.